Primecap Management Co. CA Buys Shares of 883,100 Bruker Corporation $BRKR

Primecap Management Co. CA bought a new position in shares of Bruker Corporation (NASDAQ:BRKR) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 883,100 shares of the medical research company’s stock, valued at approximately $53,145,000.

Other large investors have also recently modified their holdings of the company. Los Angeles Capital Management LLC bought a new stake in shares of Bruker during the 4th quarter worth $26,000. Global Retirement Partners LLC bought a new stake in shares of Bruker in the 2nd quarter valued at about $38,000. Parallel Advisors LLC boosted its stake in shares of Bruker by 121.0% during the fourth quarter. Parallel Advisors LLC now owns 875 shares of the medical research company’s stock valued at $41,000 after purchasing an additional 479 shares during the period. Allworth Financial LP boosted its position in Bruker by 40.6% during the 3rd quarter. Allworth Financial LP now owns 890 shares of the medical research company’s stock valued at $29,000 after buying an additional 257 shares during the period. Finally, Essential Partners LLC purchased a new stake in shares of Bruker during the first quarter worth about $36,000. Institutional investors own 79.52% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Barclays lifted their price target on shares of Bruker from $53.00 to $60.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. Citigroup decreased their target price on shares of Bruker from $60.00 to $53.00 and set a “hold” rating for the company in a research note on Wednesday, August 5th. Wall Street Zen upgraded shares of Bruker from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. JPMorgan Chase & Co. boosted their price target on Bruker from $55.00 to $65.00 and gave the stock an “overweight” rating in a research report on Monday, June 8th. Finally, Leerink Partners lifted their price objective on Bruker from $60.00 to $70.00 and gave the company an “outperform” rating in a research note on Tuesday, July 7th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, Bruker has an average rating of “Moderate Buy” and an average target price of $56.64.

Bruker Trading Up 0.4%

Shares of BRKR stock opened at $57.06 on Thursday. The company has a current ratio of 1.85, a quick ratio of 0.92 and a debt-to-equity ratio of 0.76. Bruker Corporation has a 12-month low of $28.53 and a 12-month high of $65.30. The stock has a market capitalization of $8.69 billion, a P/E ratio of -81.51, a P/E/G ratio of 1.74 and a beta of 1.28. The firm’s 50 day moving average is $58.74 and its 200 day moving average is $47.82.

Bruker (NASDAQ:BRKR) last announced its earnings results on Tuesday, August 4th. The medical research company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.11. The business had revenue of $838.50 million during the quarter, compared to analyst estimates of $853.57 million. Bruker had a negative net margin of 2.35% and a positive return on equity of 12.47%. The company’s quarterly revenue was up 5.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.32 EPS. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Research analysts expect that Bruker Corporation will post 2.12 earnings per share for the current year.

Bruker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 7th. Investors of record on Monday, September 21st will be given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, September 21st. Bruker’s dividend payout ratio is -28.57%.

Bruker Company Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.